Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT05321407
COVID-19 Vaccine Responses in PIDD Subjects
Sponsor: Duke University
View on ClinicalTrials.gov
Summary
The goal of our study is to assess the cellular immune responses of participants with antibody deficiency disease before and after immunization with SARS-CoV-2 mRNA vaccines.
Official title: Vaccine-induced SARS-CoV-2-specific T Cell Responses in Patients With Primary Immune Deficiency Disease
Key Details
Gender
All
Age Range
6 Months - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2021-09-30
Completion Date
2026-07-31
Last Updated
2025-06-03
Healthy Volunteers
Yes
Conditions
Locations (3)
University of South Florida
St. Petersburg, Florida, United States
University of North Carolina, Chapel Hill
Chapel Hill, North Carolina, United States
Duke University
Durham, North Carolina, United States